Rik Ossenkoppele

Researcher
More filtering options
  1. 2021
  2. The impact of demographic, clinical, genetic, and imaging variables on tau PET status

    Rik Ossenkoppele, Antoine Leuzy, Hanna Cho, Carole H. Sudre, Olof Strandberg, Ruben Smith, Sebastian Palmqvist, Niklas Mattsson-Carlgren, Tomas Olsson, Jonas Jögi, Erik Stormrud, Young Hoon Ryu, Jae Yong Choi, Adam L. Boxer, Maria L. Gorno-Tempini, Bruce L. Miller, David Soleimani-Meigooni, Leonardo Iaccarino, Renaud La Joie, Edilio Borroni & 7 others, Gregory Klein, Michael J. Pontecorvo, Michael D. Devous, Sylvia Villeneuve, Chul Hyoung Lyoo, Gil D. Rabinovici & Oskar Hansson, 2021 Jul 1, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, 7, p. 2245-2258 14 p.

    Research output: Contribution to journalArticle

  3. A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis

    Antoine Leuzy, Tharick A. Pascoal, Olof Strandberg, Philip Insel, Ruben Smith, Niklas Mattsson-Carlgren, Andréa L. Benedet, Hannah Cho, Chul H. Lyoo, Renaud La Joie, Gil D. Rabinovici, Rik Ossenkoppele, Pedro Rosa-Neto & Oskar Hansson, 2021 Jul, In: European Journal of Nuclear Medicine and Molecular Imaging. 48, 7, p. 2295-2305 11 p.

    Research output: Contribution to journalArticle

  4. Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework

    E. E. Wolters, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, O. Hansson, A. Nordberg, G. B. Frisoni, V. Garibotto & R. Ossenkoppele, 2021 Feb 6, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  5. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia

    Gemma Salvadó, Michel J. Grothe, Colin Groot, Alexis Moscoso, Michael Schöll, Juan Domingo Gispert & Rik Ossenkoppele, 2021 Feb 1, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  6. Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies

    Hayel Tuncel, Denise Visser, Maqsood Yaqub, Tessa Timmers, Emma E. Wolters, Rik Ossenkoppele, Wiesje M. van der Flier, Bart N.M. van Berckel, Ronald Boellaard & Sandeep S.V. Golla, 2021 Jan 26, In: Molecular Imaging and Biology.

    Research output: Contribution to journalArticle

  7. Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts

    Karine Provost, Leonardo Iaccarino, David N. Soleimani-Meigooni, Suzanne Baker, Lauren Edwards, Udo Eichenlaub, Oskar Hansson, William Jagust, Mustafa Janabi, Renaud La Joie, Orit Lesman-Segev, Taylor J. Mellinger, Bruce L. Miller, Rik Ossenkoppele, Julie Pham, Ruben Smith, Ida Sonni, Amelia Strom, Niklas Mattsson-Carlgren, Gil D. Rabinovici & 1 others, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2021 Jan 4, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  8. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups

    Colin Groot, Michel J. Grothe, Shubhabrata Mukherjee, Irina Jelistratova, Iris Jansen, Anna Catharina van Loenhoud, Shannon L. Risacher, Andrew J. Saykin, Christine L. Mac Donald, Jesse Mez, Emily H. Trittschuh, Gregor Gryglewski, Rupert Lanzenberger, Yolande A.L. Pijnenburg, Frederik Barkhof, Philip Scheltens, Wiesje M. van der Flier, Paul K. Crane & Rik Ossenkoppele, 2021 Jan, In: NeuroImage: Clinical. 30, 102660.

    Research output: Contribution to journalArticle

  9. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

    A. Leuzy, N. J. Ashton, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  10. Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease

    Ellen Singleton, Oskar Hansson, Yolande A.L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman, Erik Stomrud, Antoine Leuzy, Maurits Johansson, Olof Strandberg, Ruben Smith, Evi Berendrecht, Bruce L. Miller, Leonardo Iaccarino, Lauren Edwards, Amelia Strom, Emma E. Wolters, Emma Coomans, Denise Visser, Sandeep S.V. Golla & 9 others, Hayel Tuncel, Femke Bouwman, John Cornelis Van Swieten, Janne M. Papma, Bart Van Berckel, Philip Scheltens, Anke A. Dijkstra, Gil D. Rabinovici & Rik Ossenkoppele, 2021, (Accepted/In press) In: Journal of Neurology, Neurosurgery and Psychiatry.

    Research output: Contribution to journalArticle

  11. In vivo tau pathology is associated with synaptic loss and altered synaptic function

    Emma M. Coomans, Deborah N. Schoonhoven, Hayel Tuncel, Sander C.J. Verfaillie, Emma E. Wolters, Ronald Boellaard, Rik Ossenkoppele, Anouk den Braber, Wiep Scheper, Patrick Schober, Steven P. Sweeney, J. Michael Ryan, Robert C. Schuit, Albert D. Windhorst, Frederik Barkhof, Philip Scheltens, Sandeep S.V. Golla, Arjan Hillebrand, Alida A. Gouw & Bart N.M. van Berckel, 2021, In: Alzheimer's Research and Therapy. 13, 1, 35.

    Research output: Contribution to journalArticle

  12. Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals

    Colin Groot, Vincent Doré, Joanne Robertson, Samantha C. Burnham, Greg Savage, Rik Ossenkoppele, Christopher C. Rowe & Victor L. Villemagne, 2021, In: Neurobiology of Aging. 97, p. 41-48 8 p.

    Research output: Contribution to journalArticle

  13. The BIN1 rs744373 Alzheimer's disease risk SNP is associated with faster Aβ-associated tau accumulation and cognitive decline

    Nicolai Franzmeier, Rik Ossenkoppele, Matthias Brendel, Anna Rubinski, Ruben Smith, Atul Kumar, Niklas Mattsson-Carlgren, Olof Strandberg, Marco Duering, Katharina Buerger, Martin Dichgans, Oskar Hansson, Michael Ewers & for the Alzheimer's Disease Neuroimaging Initiative (ADNI)* and the Swedish BioFINDER study for the Alzheimer's Disease Neuroimaging Initiative (ADNI)* and the Swedish BioFINDER study, 2021, In: Alzheimer's and Dementia.

    Research output: Contribution to journalArticle

  14. The bvFTD phenocopy syndrome: a case study supported by repeated MRI, [18F]FDG-PET and pathological assessment

    Marie Paule E. van Engelen, Annemieke J.M. Rozemuller, Hülya Ulugut Erkoyun, Colin Groot, Jay L.P. Fieldhouse, Ted Koene, Rik Ossenkoppele, Flora T. Gossink, Welmoed A. Krudop, Everard G.B. Vijverberg, Annemieke Dols, Frederik Barkhof, Bart N.M.Van Berckel, Philip Scheltens, Netherlands Brain Bank & Yolande A.L. Pijnenburg, 2021, In: Neurocase.

    Research output: Contribution to journalArticle

  15. The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

    Marina Boccardi, Alessandra Dodich, Emiliano Albanese, Angèle Gayet-Ageron, Cristina Festari, Nicholas J. Ashton, Gérard N. Bischof, Konstantinos Chiotis, Antoine Leuzy, Emma E. Wolters, Martin A. Walter, Gil D. Rabinovici, Maria Carrillo, Alexander Drzezga, Oskar Hansson, Agneta Nordberg, Rik Ossenkoppele, Victor L. Villemagne, Bengt Winblad, Giovanni B. Frisoni & 1 others, Valentina Garibotto, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalArticle

  16. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers

    N. J. Ashton, A. Leuzy, T. K. Karikari, N. Mattsson-Carlgren, A. Dodich, M. Boccardi, J. Corre, A. Drzezga, A. Nordberg, R. Ossenkoppele, H. Zetterberg, K. Blennow, G. B. Frisoni, V. Garibotto & O. Hansson, 2021, In: European Journal of Nuclear Medicine and Molecular Imaging.

    Research output: Contribution to journalReview article

  17. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease

    Joana B. Pereira, Shorena Janelidze, Rik Ossenkoppele, Hlin Kvartsberg, Ann Brinkmalm, Niklas Mattsson-Carlgren, Erik Stomrud, Ruben Smith, Henrik Zetterberg, Kaj Blennow & Oskar Hansson, 2021, In: Brain : a journal of neurology. 144, 1, p. 310-324 15 p.

    Research output: Contribution to journalArticle

  18. 2020
  19. Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals

    Tessa Timmers, Rik Ossenkoppele, Denise Visser, Hayel Tuncel, Emma E. Wolters, Sander C.J. Verfaillie, Wiesje M. van der Flier, Ronald Boellaard, Sandeep S.V. Golla & Bart N.M. van Berckel, 2020 Dec 1, In: Journal of Cerebral Blood Flow and Metabolism. 40, 12, p. 2464-2474 11 p.

    Research output: Contribution to journalArticle

  20. Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease

    Denise Visser, Emma E. Wolters, Sander C.J. Verfaillie, Emma M. Coomans, Tessa Timmers, Hayel Tuncel, Juhan Reimand, Ronald Boellaard, Albert D. Windhorst, Philip Scheltens, Wiesje M. van der Flier, Rik Ossenkoppele & Bart N.M. van Berckel, 2020 Dec, In: European Journal of Nuclear Medicine and Molecular Imaging. 47, 13, p. 3165-3175 11 p.

    Research output: Contribution to journalArticle

  21. Amyloid-β PET and CSF in an autopsy-confirmed cohort

    Juhan Reimand, Baayla D.C. Boon, Lyduine E. Collij, Charlotte E. Teunissen, Annemieke J.M. Rozemuller, Bart N.M. van Berckel, Philip Scheltens, Rik Ossenkoppele & Femke Bouwman, 2020 Nov, In: Annals of Clinical and Translational Neurology. 7, 11, p. 2150-2160 11 p.

    Research output: Contribution to journalArticle

  22. Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease

    Emma E. Wolters, Rik Ossenkoppele, Sander C.J. Verfaillie, Emma M. Coomans, Tessa Timmers, Denise Visser, Hayel Tuncel, Sandeep S.V. Golla, Albert D. Windhorst, Ronald Boellaard, Wiesje M. van der Flier, Charlotte E. Teunissen, Philip Scheltens & Bart N.M. van Berckel, 2020 Nov, In: European Journal of Nuclear Medicine and Molecular Imaging. 47, 12, p. 2866-2878 13 p.

    Research output: Contribution to journalArticle

  23. Combination of plasma amyloid beta(1-42/1-40)and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

    Inge M.W. Verberk, Elisabeth Thijssen, Jannet Koelewijn, Kimberley Mauroo, Jeroen Vanbrabant, Arno De Wilde, Marissa D. Zwan, Sander C.J. Verfaillie, Rik Ossenkoppele, Frederik Barkhof, Bart N.M. Van Berckel, Philip Scheltens, Wiesje M. Van Der Flier, Erik Stoops, Hugo M. Vanderstichele & Charlotte E. Teunissen, 2020 Sep 28, In: Alzheimer's Research and Therapy. 12, 1, 118.

    Research output: Contribution to journalArticle

  24. Assessment of Demographic, Genetic, and Imaging Variables Associated with Brain Resilience and Cognitive Resilience to Pathological Tau in Patients with Alzheimer Disease

    Rik Ossenkoppele, Chul Hyoung Lyoo, Jonas Jester-Broms, Carole H. Sudre, Hanna Cho, Young Hoon Ryu, Jae Yong Choi, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Joel Kramer, Adam L. Boxer, Maria L. Gorno-Tempini, Bruce L. Miller, Renaud La Joie, Gil D. Rabinovici & Oskar Hansson, 2020 May, In: JAMA Neurology. 77, 5, p. 632-642 11 p.

    Research output: Contribution to journalArticle

  25. Identifying a task-invariant cognitive reserve network using task potency

    A. C. van Loenhoud, C. Habeck, W. M. van der Flier, R. Ossenkoppele & Y. Stern, 2020 Apr 15, In: NeuroImage. 210, 116593.

    Research output: Contribution to journalArticle

  26. Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease

    Rik Ossenkoppele, Chul Hyoung Lyoo, Carole H. Sudre, Danielle van Westen, Hanna Cho, Young Hoon Ryu, Jae Yong Choi, Ruben Smith, Olof Strandberg, Sebastian Palmqvist, Erik Westman, Richard Tsai, Joel Kramer, Adam L. Boxer, Maria L. Gorno-Tempini, Renaud La Joie, Bruce L. Miller, Gil D. Rabinovici & Oskar Hansson, 2020 Feb, In: Alzheimer's and Dementia. 16, 2, p. 335-344 10 p.

    Research output: Contribution to journalArticle

  27. Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?

    Juhan Reimand, Colin Groot, Charlotte E. Teunissen, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Sergei Nazarenko, Wiesje M. van der Flier, Bart N.M. van Berckel, Philip Scheltens, Rik Ossenkoppele & Femke Bouwman, 2020 Jan 21, In: Journal of Alzheimer's disease : JAD. 73, 2, p. 559-569 11 p.

    Research output: Contribution to journalArticle

  28. A clinical-radiological framework of the right temporal variant of frontotemporal dementia

    Hulya Ulugut Erkoyun, Colin Groot, Ronja Heilbron, Anne Nelissen, Jonathan van Rossum, Roos Jutten, Ted Koene, Wiesje M. van der Flier, Mike P. Wattjes, Philip Scheltens, Rik Ossenkoppele, Frederik Barkhof & Yolande Pijnenburg, 2020, In: Brain : a journal of neurology. 143, 9, p. 2831-2843 13 p.

    Research output: Contribution to journalArticle

  29. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    Gaël Chételat, Javier Arbizu, Henryk Barthel, Valentina Garibotto, Ian Law, Silvia Morbelli, Elsmarieke van de Giessen, Federica Agosta, Frederik Barkhof, David J. Brooks, Maria C. Carrillo, Bruno Dubois, Anders M. Fjell, Giovanni B. Frisoni, Oskar Hansson, Karl Herholz, Brian F. Hutton, Clifford R. Jack, Adriaan A. Lammertsma, Susan M. Landau & 11 others, Satoshi Minoshima, Flavio Nobili, Agneta Nordberg, Rik Ossenkoppele, Wim J.G. Oyen, Daniela Perani, Gil D. Rabinovici, Philip Scheltens, Victor L. Villemagne, Henrik Zetterberg & Alexander Drzezga, 2020, In: The Lancet Neurology. 19, 11, p. 951-962 12 p.

    Research output: Contribution to journalReview article

  30. Amyloid-β-independent regulators of tau pathology in Alzheimer disease

    Rik van der Kant, Lawrence S.B. Goldstein & Rik Ossenkoppele, 2020, In: Nature Reviews Neuroscience. 21, 1, p. 21-35 15 p.

    Research output: Contribution to journalReview article

  31. Association of amyloid-β CSF/PET discordance and tau load 5 years later

    Juhan Reimand, Lyduine Collij, Philip Scheltens, Femke Bouwman, Rik Ossenkoppele & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2020, In: Neurology. 95, 19, p. e2648-e2657

    Research output: Contribution to journalArticle

  32. Comorbid amyloid-β pathology affects clinical and imaging features in VCD

    Jolien F. Leijenaar, Colin Groot, Carole H. Sudre, David Bergeron, Anna E. Leeuwis, M. Jorge Cardoso, Ferran Prados Carrasco, Robert Laforce, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Niels D. Prins & Rik Ossenkoppele, 2020, In: Alzheimer's and Dementia. 16, 2, p. 354-364 11 p.

    Research output: Contribution to journalArticle

  33. Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load

    Antoine Leuzy, Johan Lilja, Christopher J. Buckley, Rik Ossenkoppele, Sebastian Palmqvist, Mark Battle, Gill Farrar, Dietmar R. Thal, Shorena Janelidze, Erik Stomrud, Olof Strandberg, Ruben Smith & Oskar Hansson, 2020, In: Neurology. 95, 21, p. e2834-e2844

    Research output: Contribution to journalArticle

  34. Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships

    Emma E. Wolters, Rik Ossenkoppele, Sandeep SV Golla, Sander CJ Verfaillie, Tessa Timmers, Denise Visser, Hayel Tuncel, Emma M. Coomans, Albert D. Windhorst, Philip Scheltens, Wiesje M. van der Flier, Ronald Boellaard & Bart NM van Berckel, 2020, In: NeuroImage: Clinical. 25, 102113.

    Research output: Contribution to journalArticle

  35. Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease

    Ellen H. Singleton, Yolande A.L. Pijnenburg, Carole H. Sudre, Colin Groot, Elena Kochova, Frederik Barkhof, Renaud La Joie, Howard J. Rosen, William W. Seeley, Bruce Miller, M. Jorge Cardoso, Janne Papma, Philip Scheltens, Gil D. Rabinovici & Rik Ossenkoppele, 2020, In: Alzheimer's Research and Therapy. 12, 1, 148.

    Research output: Contribution to journalArticle

  36. Latent atrophy factors related to phenotypical variants of posterior cortical atrophy

    Colin Groot, B. T.Thomas Yeo, Jacob W. Vogel, Xiuming Zhang, Nanbo Sun, Elizabeth C. Mormino, Yolande A.L. Pijnenburg, Bruce L. Miller, Howard J. Rosen, Renaud La Joie, Frederik Barkhof, Philip Scheltens, Wiesje M. van der Flier, Gil D. Rabinovici & Rik Ossenkoppele, 2020, In: Neurology. 95, 12, p. e1672-e1685

    Research output: Contribution to journalArticle

  37. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease

    Nicolai Franzmeier, Anna Dewenter, Lukas Frontzkowski, Martin Dichgans, Anna Rubinski, Julia Neitzel, Ruben Smith, Olof Strandberg, Rik Ossenkoppele, Katharina Buerger, Marco Duering, Oskar Hansson & Michael Ewers, 2020, In: Science Advances. 6, 48, abd1327.

    Research output: Contribution to journalArticle

  38. [11C]PIB amyloid quantification: effect of reference region selection

    Fiona Heeman, Janine Hendriks, Isadora Lopes Alves, Rik Ossenkoppele, Nelleke Tolboom, Bart N.M. van Berckel, Adriaan A. Lammertsma, Maqsood Yaqub & AMYPAD Consortium AMYPAD Consortium, 2020, In: EJNMMI Research. 10, 1, 123.

    Research output: Contribution to journalArticle

  39. Tau PET and relative cerebral blood flow in dementia with Lewy bodies: A PET study

    E. E. Wolters, M. van de Beek, R. Ossenkoppele, S. S.V. Golla, S. C.J. Verfaillie, E. M. Coomans, T. Timmers, D. Visser, H. Tuncel, F. Barkhof, R. Boellaard, A. D. Windhorst, W. M. van der Flier, Ph Scheltens, A. W. Lemstra & B. N.M. van Berckel, 2020, In: NeuroImage: Clinical. 28, 102504.

    Research output: Contribution to journalArticle

  40. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects

    Ruben Smith, Olof Strandberg, Niklas Mattsson-Carlgren, Antoine Leuzy, Sebastian Palmqvist, Michael J. Pontecorvo, Michael D. Devous, Rik Ossenkoppele & Oskar Hansson, 2020, In: Brain. 143, 12, p. 3805-3815 11 p.

    Research output: Contribution to journalArticle

  41. 2019
  42. High occurrence of transportation and logistics occupations among vascular dementia patients: An observational study

    A. C. Van Loenhoud, C. De Boer, K. Wols, Y. A. Pijnenburg, A. W. Lemstra, F. H. Bouwman, N. D. Prins, P. Scheltens, R. Ossenkoppele & W. M. Van Der Flier, 2019 Dec 27, In: Alzheimer's Research and Therapy. 11, 1, 112.

    Research output: Contribution to journalArticle

  43. Applying the ATN scheme in a memory clinic population: The ABIDE project

    Daniele Altomare, Arno de Wilde, Rik Ossenkoppele, Wiesje Pelkmans, Femke Bouwman, Colin Groot, Ingrid van Maurik, Marissa Zwan, Maqsood Yaqub, Frederik Barkhof, Bart N. van Berckel, Charlotte E. Teunissen, Giovanni B. Frisoni, Philip Scheltens & Wiesje M. van der Flier, 2019 Oct 22, In: Neurology. 93, 17, p. e1635-e1646

    Research output: Contribution to journalArticle

  44. Prognostic value of Alzheimer’s biomarkers in mild cognitive impairment: the effect of age at onset

    Daniele Altomare, Clarissa Ferrari, Anna Caroli, Samantha Galluzzi, Annapaola Prestia, Wiesje M. van der Flier, Rik Ossenkoppele, Bart Van Berckel, Frederik Barkhof, Charlotte E. Teunissen, Anders Wall, Stephen F. Carter, Michael Schöll, Il Han Choo, Timo Grimmer, Alberto Redolfi, Agneta Nordberg, Philip Scheltens, Alexander Drzezga, Giovanni B Frisoni & 1 others, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2019 Oct, In: Journal of Neurology. 266, 10, p. 2535–2545 10 p.

    Research output: Contribution to journalArticle

  45. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

    Arno De Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. Van Der Flier, Philip Scheltens, Bart N.M. Van Berckel, Femke Bouwman & Rik Ossenkoppele, 2019 Sep 12, In: Alzheimer's Research and Therapy. 11, 78.

    Research output: Contribution to journalArticle

  46. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship

    Anna Catharina van Loenhoud, Wiesje Maria van der Flier, Alle Meije Wink, Ellen Dicks, Colin Groot, Jos Twisk, Frederik Barkhof, Philip Scheltens, Rik Ossenkoppele & Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative, 2019 Jul 23, In: Neurology. 93, 4, p. e334-e346

    Research output: Contribution to journalArticle

  47. Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum

    Tessa Timmers, Rik Ossenkoppele, Emma E. Wolters, Sander C.J. Verfaillie, Denise Visser, Sandeep S.V. Golla, Frederik Barkhof, Philip Scheltens, Ronald Boellaard, Wiesje M. Van Der Flier & Bart N.M. Van Berckel, 2019 Jul 4, In: Alzheimer's Research and Therapy. 11, 1, 60.

    Research output: Contribution to journalArticle

Previous 1 2 Next